Aptevo Therapeutics Inc
F:AP8N
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Aptevo Therapeutics Inc
F:AP8N
|
US |
|
P
|
Paninvest Tbk PT
XMUN:OA9
|
ID |
|
R
|
Ruby Tech Corp
TPEX:8048
|
TW |
|
Sealand Capital Galaxy Ltd
F:7KM
|
KY |
|
C
|
CrownHaitai Holdings Co Ltd
KRX:005740
|
KR |
|
T
|
Tempus Resources Ltd
XTSX:TMRR
|
AU |
|
Singapore Shipping Corporation Ltd
SGX:S19
|
SG |
|
R
|
Ratnabhumi Developers Ltd
BSE:540796
|
IN |
|
R
|
RC365 Holding PLC
F:L2G
|
UK |
|
Limak Dogu Anadolu Cimento Sanayi ve Ticaret AS
IST:LMKDC.E
|
TR |
|
V
|
Vgi Partners Ltd
ASX:VGI
|
AU |
|
Barrett Business Services Inc
F:BB1
|
US |
|
M
|
Muro Corp
TSE:7264
|
JP |
|
Circio Holding ASA
F:TA50
|
NO |
|
V
|
Viavi Solutions Inc
XMUN:UNS1
|
US |
|
S
|
Subaru Corp
SWB:FUH
|
JP |
Bankruptcy Probability
Aptevo Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Aptevo Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Aptevo Therapeutics Inc
NASDAQ:APVO
|
3m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
464.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
238.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
183.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
138.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
84.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
56.7B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
59.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Aptevo Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Aptevo Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
